Patents by Inventor Hidetoshi Hiranuma

Hidetoshi Hiranuma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4607034
    Abstract: There are presented novel quinazoline derivatives, namely 2-(4-substituted-carbamoyl-piperazin-1-yl)quinazoline derivatives, 2-(4-substituted-carbamoyl-homopiperazin-1-yl)quinazoline derivatives, 2-(4-substituted-thiocarbamoyl-piperazin-1-yl)quinazoline derivatives and 2-(4-substituted-thiocarbamoyl-piperazin-1-yl)quinazoline derivatives, having excellent antihypertensive activities.
    Type: Grant
    Filed: October 21, 1980
    Date of Patent: August 19, 1986
    Assignee: Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Susumu Mizogami, Hidetoshi Hiranuma, Tetsuo Sekiya, Mitsuo Hanazuka
  • Patent number: 4352928
    Abstract: There are provided a novel compound, i.e., a 2-piperazino-4-substituted-5,6-alkylenepyrimidine derivative represented by the formula: ##STR1## wherein Y, Z and n are defined in the specification and claims, and a pharmaceutically acceptable acid addition salt thereof.The compounds of the present invention show, an anti-inflammatory effect, a blood sugar level lowering effect, a blood platelet aggregation suppressive effect, an anorexigenic action and a Serotonin effect.
    Type: Grant
    Filed: June 16, 1980
    Date of Patent: October 5, 1982
    Assignee: Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Hidetoshi Hiranuma, Tetsuo Sekiya, Susumu Mizogami, Motokuni Mori, Mitsuo Hanatsuka, Toshiji Kanayama
  • Patent number: 4189484
    Abstract: Novel quinazoline compounds and antihypertensive compositions containing said compounds are disclosed; said compounds having the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or an alkyl group having 1-5 carbon atoms;R.sup.2 is a group of the formula ##STR2## in which Y is a hydrogen atom, an alkyl group of 1-5 carbon atoms, an alkoxy group of 1-5 carbon atoms, an alkenyloxy group, a methylenedioxy group, a nitro group, a halogen atom, a trifluoromethyl group, an acyloxy group, a hydroxy group, an unsubstituted or substituted amino group or a condensed benzene nucleus and m is an integer of 1-3 inclusive, or a group of the formula ##STR3## in which X is an oxygen atom, a sulfur atom or a carbon-nitrogen double bond and Z is a hydrogen atom, an alkyl group of 1-5 carbon atoms, an alkoxy group of 1-5 carbon atoms, a nitro group or a halogen atom; and n is an integer of 2-3 inclusive;provided that, when R.sup.2 is the said group ##STR4## n is 2 and R.sup.1 is a hydrogen atom or, when R.sup.
    Type: Grant
    Filed: October 31, 1978
    Date of Patent: February 19, 1980
    Assignee: Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Susumu Mizogami, Hidetoshi Hiranuma, Tetsuo Sekiya, Mitsuo Hanazuka
  • Patent number: 4016193
    Abstract: Novel substituted phenylacetic acid derivatives having the formula: ##STR1## wherein R.sub.1 represents a hydrogen atom or lower alkyl radical and R.sub.3 represents an alkenyl or alkynyl radical having 3 - 4 carbon atoms with excellent anti-inflammatory and analgesic activities.
    Type: Grant
    Filed: July 3, 1975
    Date of Patent: April 5, 1977
    Assignee: Mitsubishi Yuka Pharmaceutical Co., Ltd.
    Inventors: Toshihiko Kobayashi, Hidetoshi Hiranuma, Susumu Mizogami, Hiroyoshi Nishi, Mamoru Higuchi, Masatoshi Onoya